that i NKT cells recognize glycolipids presented by CD1d, how and where they encounter antigen in vivo remains unclear. Here we used multiphoton microscopy to visualize the dynamics and activation of i NKT cells in lymph nodes. After antigen administration, i NKT cells became confined in a CD1d-dependent manner in close proximity to subcapsular sinus CD169 + macrophages. These macrophages retained, internalized and presented lipid antigen and were required for i NKT cell activation, cytokine production and population expansion. Thus, CD169 + macrophages can act as true antigen-presenting cells controlling early i NKT cell activation and favoring the fast initiation of immune responses.
Invariant natural killer T cells (iNKT cells) are a specialized subset of classical αβ T lymphocytes that have been linked to a wide range of immune responses, including antiviral, antibacterial, inflammatory and autoimmune reactions 1 . These iNKT cells are characterized by expression of a restricted αβ T cell antigen receptor (TCR) repertoire composed of the canonical variable α-region 14-joining α-region 18 (V α 14-J α 18) chain in association with the V β 2, V β 7 or V β 8 chain in mice (equivalent to V α 24-J α 18 and V β 11 in humans) 2 . Through these TCRs, iNKT cells specifically recognize lipid antigens presented by CD1d, a major histocompatibility complex class I-like molecule expressed by professional antigen-presenting cells (APCs), including dendritic cells (DCs), macrophages and B cells 3 . Several lipid antigens able to directly activate iNKT cells have been identified, including glycolipids from lipopolysaccharide-negative bacteria such as Sphingomonas, Erlichia and Borrelia [4] [5] [6] . Furthermore, it has been suggested that in response to Toll-like receptor stimulation of professional APCs, a combination of enhanced secretion of interleukin 12 (IL-12) and upregulation of endogenous lipid(s) may also activate iNKT cells in a CD1d-dependent manner [6] [7] [8] [9] or CD1d-independent manner 10 . Activated iNKT cells very rapidly secrete large quantities of cytokines, such as interferon-γ (IFN-γ) and IL-4, and induce downstream activation of a variety of other cell types, including DCs, NK cells, B cells and classical T cells. Thus, iNKT cells may have a pivotal position in coordinating both innate and adaptive immune responses 1, 2 .
The iNKT cells occupy a tissue distribution similar to that of classical αβ T cells 2 , although the relative proportion of iNKT cells varies according to the particular location. For example, iNKT cells constitute around 30%, 2-3% and up to 0.5% of the total αβ T cell population in the liver, spleen and lymph nodes, respectively. Under physiological conditions of clonal abundance, iNKT cells exceed the number of antigen-specific αβ T cells by around 500-to 5,000-fold in the lymph node (~1 in 1 × 10 5 to 1 × 10 6 T cells 11 ). Thus, although the relative number of iNKT cells in secondary lymphoid tissues may seem small on first examination, it is likely that they make an important contribution in the regulation of immune responses in these sites. However, very few studies so far have attempted to investigate the role of iNKT cells in the lymph nodes 12, 13 .
Despite the key role of iNKT cells in the host defense against microbial infection 14 , the mechanism by which these cells encounter antigen and become activated in vivo has not been fully investigated. As CD1d is expressed on a wide variety of cell types 15 , many cells could be potentially involved in mediating antigen presentation and subsequent activation of iNKT cells in vivo. Several studies have suggested that DCs and Kupffer cells have an important role in presenting glycolipids to iNKT cells in the spleen and liver 16, 17 . In fact, administration of DCs pulsed in vitro with bacteria such as Sphingomonas and Borrelia or various glycolipids can stimulate activation of iNKT cells in vivo [4] [5] [6] 16 . Two studies have analyzed the dynamics of a population of CXCR6 + cells (mainly composed of NKT cells) in the liver by confocal microscopy 18, 19 . These studies have demonstrated that CXCR6 + cells become arrested in hepatic sinusoids after the administration of antigenic lipids. However, the events that underlie iNKT cell activation, including the cells involved in antigen internalization and presentation, have not been fully investigated in living lymphoid organs.
Much of the present understanding of the mechanisms of antigen presentation and lymphocyte activation in secondary lymphoid organs has been provided by innovative intravital imaging in the lymph node 20 . After administration, a first wave of antigen is rapidly A r t i c l e s delivered to draining lymph nodes through afferent lymphatic vessels and is moved around the subcapsular sinus (SCS). Large antigens such as viruses, pathogens and immune complexes are restricted from gaining access to the lymph node interior, as they are retained by cells lining the SCS and are presented to antigen-specific B cells and T cells directly in the lymph node periphery [21] [22] [23] [24] [25] . Several hours after the initial administration, a second wave of antigen arrives at the lymph node in association with migratory peripheral DCs, which allows presentation to cognate T lymphocytes deep in the lymph node cortex 26 . It is likely that during an immune response, these two waves of presentation act together to maximize the probability that lymphocytes encounter their cognate antigen; however, the contribution (if any) that either could make to iNKT cell activation in the lymph node is not fully understood.
Here we investigate the early events that control the activation of iNKT cells in response to specific antigens. We used multiphoton microscopy to visualize the dynamics of iNKT cells in intact lymph nodes. We found that iNKT cells were located mainly in the paracortical region, similar to classical CD4 + T cells, while they searched the lymph node for specific antigen. Within hours of administration, lipid antigen retained at the SCS region stimulated the arrest of iNKT cells at this site. Furthermore, we found that CD169 + macrophages in the SCS mediated long-lasting interactions with iNKT cells in a CD1d-dependent manner, which resulted in very fast iNKT cell activation and cytokine secretion. Thus, we have identified an additional role for SCS macrophages in presenting lipid antigen to mediate the rapid activation of iNKT cells in the lymph node, which is probably important during the early stages of immune responses.
RESULTS

Distribution and dynamics of iNKT cells in the lymph nodes
We wanted to investigate the distribution and dynamics of iNKT cells in the lymph nodes. Given the relatively small number (Fig. 1a,b ) and heterogeneity 12, 27, 28 of these cells and the lack of reagents for reliable unambiguous identification of iNKT cells by immunohistochemistry in situ 29 , we used adoptive transfer and multiphoton microscopy to visualize iNKT cells in the lymph nodes. To overcome the limitations that might be associated with the isolation of heterogeneous populations, we used two complementary flow cytometry sorting strategies that allowed us to obtain highly pure iNKT cells. We defined these two strategies as follows: 'iNKT-S1 cells' for iNKT cells sorted from lymph nodes as α-galactosylceramide (α-GalCer)-loaded CD1d tetramer-positive (CD1d-tet + )TCRβ + B220 − cells (>97% purity; Supplementary Fig. 1a,b) ; and 'iNKT-S2 cells' for iNKT cells sorted from spleen and liver as TCRβ + NK1.1 + B220 − cells (>95% CD1d-tet + cells; Fig. 1c and Supplementary Fig. 2a ). Although we obtained more iNKT cells from spleen and liver, iNKT cells sorted from lymph nodes more closely represented the relative proportions of NK1.1 + and NK1.1 − iNKT cells found in the lymph nodes of wild-type mice (Supplementary Fig. 1 ). We independently transferred the resulting iNKT cells sorted by these two approaches into C57BL/6 recipient mice. Regardless of the tissue of origin or the purification strategy, transferred iNKT cells homed to lymph nodes, where they represented around 0.05-0.1% of total TCRβ + T cells ( Fig. 1d and Supplementary Figs. 1c and 2b) . Thus, both strategies allowed analysis of iNKT cell distribution in conditions resembling those of clonal abundance in resting lymph nodes, where endogenous iNKT cells represent around 0.3% of total T cells.
To visualize iNKT cell distribution in the lymph node, we labeled iNKT-S1 and iNKT-S2 cells with the fluorescent dye CFSE and independently transferred them into C57BL/6 recipient mice, along with B cells labeled with the fluorescent dye CMAC and CD4 + T cells labeled with the fluorescent dye SNARF-1 to define the follicular and paracortical regions of the lymph nodes, respectively. At 16 h after transfer, we killed the mice and removed and fixed their lymph nodes, which we imaged as intact nodes by multiphoton microscopy. We acquired adjacent sections 5 µm in thickness through the lymph node and assembled them in three dimensions to allow visualization of iNKT cells up to a depth greater than 400 µm below the surface of the node (Fig. 1e,f and Supplementary Fig. 1d,e) . Independently of the tissue of origin or the purification strategy, iNKT cells were 'preferentially' located in the paracortex alongside CD4 + T cells. Although by analysis of z-projected images we occasionally found iNKT cells in the B cell follicles, careful examination of three-dimensional reconstructions of the lymph nodes showed that these iNKT cells were located around the periphery of follicles and were essentially excluded from the B cell areas. We detected about 10% of iNKT cells in interfollicular regions or in close proximity to the SCS (Fig. 1e,f and Supplementary Fig. 1d,e) .
To characterize the dynamics of iNKT cells in living lymph nodes, we used multiphoton microscopy to image intact lymph nodes from mice that had undergone adoptive transfer of iNKT cells purified by each regime described above. We observed that iNKT cells traversed the lymph node with an average speed of 11.0 ± 3.1 and 10.0 ± 3.2 µm/min for iNKT-S1 cells and iNKT-S2 cells, respectively ( Fig. 1g and Supplementary Movies 1 and 2). The average speed of iNKT cells was similar to that of cotransferred CD4 + T cells and was around twofold greater than that of cotransferred B cells (10.1 ± 4.0 µm/min and 5.4 ± 2.4 µm/min, respectively), in agreement with published observations 20, 30 . Closer inspection showed that the distribution of instantaneous speeds for individual iNKT and CD4 + T cells was similar, with a maximum of around 30 µm/min (Fig. 1h) . To gain insight into the nature of the movements of iNKT cells in the lymph node, we used the arrest coefficient to represent the proportion of the time during a given track in which a cell was stopped (Fig. 1i) . In addition, the confinement index denoted whether cells were restricted to a particular area during the imaging period (Fig. 1j) . This analysis showed that iNKT cells acted like CD4 + T cells, with similar arrest coefficient and confinement index values (Fig. 1i,j) . Furthermore, the mean absolute displacement increased proportionally with the square root of time (Fig. 1k) , which indicated that both iNKT and CD4 + T cells move by a random walk mode 20, 30 . On the basis of those results, we calculated motility coefficients of 70.3 ± 17.1 and 65.9 ± 4.6 µm 2 /min for iNKT-S1 cells and iNKT-S2 cells, respectively, and 73.8 ± 14.4 µm 2 /min for CD4 + T cells, which indicated that these cells are able to scan similar volumes of the lymph node in a given time. Notably, iNKT cells purified by our two different strategies showed similar distributions and dynamics in the lymph node independently of their tissue of origin or purification method. Therefore, we conclude that iNKT cells are located mainly in the paracortical region and patrol resting lymph nodes with a random walk, showing dynamic characteristic similar to those of classical CD4 + T cells.
Early activation of lymph node iNKT cells
Next we examined whether iNKT cells are activated by lipid antigens that drain into lymph nodes. To mimic the conditions of infection with bacteria encoding iNKT cell agonists [4] [5] [6] 14 , we injected silica particles 200 nm in diameter 31 coated with α-GalCer (200 ng α-GalCer per 1 µl particles; ~1 × 10 9 particles per µl). We used particles coated with nonstimulatory lipids as controls in all experiments 31 . We injected wild-type C57BL/6 mice with particulate α-GalCer and found that by 3 d after injection, lymph nodes were enlarged, with cell numbers around three times those of lymph nodes from mice injected with control particles (Fig. 2a,b) . This enlargement was dependent on the presence of iNKT cells, as we did not detect it in J α 18-deficient mice (which lack NKT cells) injected with α-GalCer particles (Fig. 2b) . Despite the greater cellularity, the relative proportions of various other cell types (including B cells, T cells, NK cells and DCs) were unaffected, except that the lymph nodes of mice injected with particulate α-GalCer were highly enriched for iNKT cells relative to those of control mice (Fig. 2c-f) . Accordingly, the frequency of iNKT cells in draining lymph nodes was up to tenfold higher than that of total TCRβ + cells, but the frequency of iNKT cells in nondraining nodes was not (Fig. 2d-f) . Thus, intraperitoneal injection of particulate antigen increased the frequency of iNKT cells in the mediastinal lymph nodes (Fig. 2e) , consistent with the idea that mediastinal lymph nodes drain the peritoneal cavity 32, 33 , whereas subcutaneous footpad injection enlarged the population of iNKT cells in the draining popliteal lymph nodes (Fig. 2f) . We detected no change in the frequency of iNKT cells in draining lymph nodes after injection of control particles coated with nonstimulatory lipids (Fig. 2d) . Moreover, we observed CFSE dilution in adoptively transferred iNKT cells 2 d after injection of particulate lipid antigen, which indicated that the greater frequency of iNKT cells in draining lymph nodes was due at least in part to antigen-induced proliferation (Fig. 2g) .
When we analyzed the activation of endogenous iNKT cells within the first hours after antigen administration, we detected that as early as 6 h after injection, iNKT cells in draining lymph nodes upregulated their expression of CD25 (Fig. 2h-j) and CD69 (Fig. 2k) , which indicated that antigen recognition takes place in the nodes in the very early hours after administration. Moreover, both NK1.1 + and NK1.1 − iNKT cell populations in the lymph nodes had identical upregulation of CD25 and CD69 after injection of particulate lipid antigen (Fig. 2l) . In agreement with the ability of iNKT cells to rapidly secrete large amounts of cytokines after activation 27 , we observed production of IFN-γ by lymph node iNKT cells at 12 h after antigen injection, which we detected by ex vivo intracellular staining of lymph node single-cell suspensions without the addition of brefeldin A (Fig. 2m) . Thus, iNKT cells are rapidly activated in the lymph nodes in response to antigen administration, which indicates that they may have a role in the early initiation of immune responses in draining nodes.
Dynamics of iNKT cells in response to specific antigen
Published investigations have shown that the dynamics of B cells and T cells in lymph nodes are altered after administration of cognate antigen 20 . Accordingly, we used multiphoton microscopy to examine the dynamics of iNKT cells adoptively transferred into C57BL/6 wild-type mice in the lymph nodes at various times after administration of particulate lipid antigen. We observed that iNKT cells had a decrease in average speed as early as 2 h after injection of particulate lipid antigen (6.5 ± 3.4 µm/min for iNKT-S2 cells), which became more apparent 
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by 16 h after injection (3.8 ± 2.4 µm/min and 2.9 ± 1.8 µm/min for iNKT-S2 cells and iNKT-S1 cells, respectively; Fig. 3a , Supplementary  Fig. 3a and Supplementary Movies 3 and 4). This decrease in speed was accompanied by an increase in long-lasting arrests, reflected in both an altered distribution of instantaneous speeds ( Fig. 3b and Supplementary Fig. 3b ) and a higher arrest coefficient ( Fig. 3c and Supplementary Fig. 3c ). In addition, we observed that iNKT cells become more confined after antigen administration, as shown by the constriction of the migratory trajectories ( Fig. 3d and Supplementary  Fig. 3e ) and increase in confinement index ( Fig. 3e and Supplementary  Fig. 3d ). Furthermore, the motility coefficient of iNKT cells was diminished to 5.0 ± 2.8 µm 2 /min and 3.8 ± 3.3 µm 2 /min for iNKT-S2 cells and iNKT-S1 cells, respectively, in response to particulate lipid antigen ( Fig. 3f and Supplementary Fig. 3f ). The speed and confinement of CD4 + T cells were not affected by the injection of particles coated with lipid antigen (Fig. 3a-f and Supplementary Fig. 3 ). Thus, iNKT cells purified by our two different strategies showed identical dynamic activity in response to the administration of specific antigen.
To ascertain if the observed arrest of iNKT cells was dependent on CD1d-mediated antigen presentation, we used CD1d-deficient mice as recipients of adoptive transfer of iNKT-S2 and CD4 + T cells. At 16 h after the administration of particulate lipid antigen, iNKT cells acted like CD4 + T cells and did not show a lower average speed ( Fig. 3g and Supplementary Movie 5). In addition, the migratory trajectories and confinement index of iNKT cells transferred into CD1d-deficient mice were not altered after the administration of antigen (Fig. 3h,i) . Thus, in the absence of CD1d-mediated presentation, the dynamics of iNKT cells in response to specific antigen administration was indistinguishable from that of CD4 + T cells. Together these findings demonstrate that lymph node iNKT cells become confined as a result of CD1d-mediated antigen presentation within hours of the administration of particulate lipid antigen.
Arrest of iNKT cells on CD169 + SCS macrophages
Given that iNKT cells in draining lymph nodes were activated in response to specific lipid antigen in a CD1d-dependent manner, we investigated both the site of and the APCs involved in antigen presentation to iNKT cells. To achieve this, we used fluorescence-labeled particulate lipids and tracked their distribution in the lymph nodes by a combination of flow cytometry and confocal microscopy plus multiphoton microscopy. Within minutes of injection, we detected particulate lipid antigen mainly in the SCS and medullary regions of the draining lymph nodes (Supplementary Fig. 4a-e) . When we visualized the dynamics of iNKT-S2 cells in the lymph node after antigen arrival by multiphoton microscopy, we observed that as soon as 2 h after injection, adoptively transferred iNKT cells moved toward the SCS and were confined in the vicinity of antigen-rich areas (Fig. 4a,  Supplementary Fig. 5a and Supplementary Movie 6). Furthermore, at 16 h after antigen administration, these iNKT cells were present mainly in the lymph node periphery and, in agreement with our data above, showed long-lasting arrests (Fig. 4b, Supplementary Fig. 5b and Supplementary Movie 7). We also found iNKT-S1 cells in close proximity to the SCS region at 16 h after injection of particulate lipid antigen ( Supplementary Fig. 5c and Supplementary Movie 8). CD169 + macrophages can mediate the retention of antigen in the SCS region of lymph nodes 21, [23] [24] [25] 34, 35 . Consistent with that, at 2 h after administration we observed the arrival of particulate lipid antigen in the lymph nodes and its localization with CD169 + macrophages and in association with LYVE-1 + lymphatic vessels ( Fig. 4c  and Supplementary Fig. 4f) . Accordingly, we detected particles with over 50% CD169 + CD11b + cells in the draining lymph nodes by flow cytometry within 4 h of antigen administration (Fig. 4d) . We observed no antigen retention by CD11c hi conventional DCs at this time point (Fig. 4c,d) . To further characterize the activity of lymph node iNKT cells after antigen arrival, we visualized iNKT-S2 cells in recipient mice injected with fluorescence-labeled antibody to mouse CD169 (anti-mouse CD169) 34 plus labeled particulate α-GalCer or control lipids (Fig. 4e) . We fixed the lymph nodes of recipient mice, imaged them by multiphoton microscopy and analyzed the location of iNKT cells relative to that of SCS CD169 + macrophages. CD169 + cells formed a layer in the SCS of the lymph nodes that retained particulate lipids (Fig. 4e) . Within 6 h of antigen administration, we observed that iNKT cells were retained in the vicinity of the SCS and that approximately 55% (40 of 75 iNKT cells) established direct contact (<5 µm apart) with CD169 + macrophages (Fig. 4e,f) . In contrast, after the administration of particles containing nonstimulatory lipids iNKT cells were located mainly in deeper regions of the lymph node, with few (18%; 10 of 54 iNKT cells) making contact with SCS macrophages (Fig. 4e,f) . Furthermore, imaging of living lymph nodes showed that iNKT cells stopped in the SCS region and established long-lasting interactions with particle-containing macrophages by 6 h after antigen injection. A large proportion of iNKT cell-macrophage contacts (81%; 59 of 73) lasted the full duration of the 20-minute imaging period and we rarely observed dissociation of these conjugates (19%; 14 of 73) ( Fig. 4g and Supplementary Movies 9 and 10) . Thus, iNKT cells make specific and long-lasting contacts with antigen-loaded CD169 + macrophages within a few hours of the arrival of antigen at the draining lymph node.
Activation of iNKT cells requires lymph node macrophages
To establish if macrophages are able to mediate iNKT cell activation in the lymph nodes, we depleted mice of lymph node-resident macrophages by treating them with clodronate liposomes (CLLs). In agreement with published reports 23 , we observed that CCLs 'preferentially' depleted only draining lymph nodes of macrophages, leaving nondraining lymph nodes intact (data not shown). Although CLL treatment induced greater total cell numbers in draining lymph nodes, it did not alter the relative proportion of B cells, T cells, DCs and iNKT cells (Fig. 5a,b and Supplementary Fig. 6a ) or the gross morphological structure of the lymph node (Supplementary Fig. 6c ). In addition, macrophage depletion did not affect the basal state of iNKT cells, as CD25 expression remained unchanged after CLL treatment (Supplementary Fig. 6b) .
To analyze the role of macrophages in iNKT cell activation, we injected macrophage-depleted and control mice with particulate lipids. In the absence of macrophages, we detected particulate lipids mainly deep in the B cell follicles and in medullary regions (Supplementary Fig. 6d) . By 12 h after the injection of particulate lipid antigen, we observed that CD25 upregulation by iNKT cells was lower in the draining lymph nodes of CCL-treated mice than in those of untreated mice (Fig. 5c) . Furthermore, macrophage depletion prevented the population expansion of iNKT cells 3 d after the administration of antigen, as reflected by the percentage and number of iNKT cells in draining lymph nodes (Fig. 5d-f) . Therefore, selective macrophage depletion in the lymph nodes leads to inefficient iNKT cell activation and prevents expansion of the iNKT cell population. 
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CD169 + macrophages present antigen to i NKT cells
Next we investigated the possibility that CD169 + macrophages participate directly in the presentation of antigenic lipids to iNKT cells. We observed by flow cytometry that CD169 + macrophages expressed cell surface CD1d (Fig. 6a) . We then enriched CD11b + cells from single-cell suspensions of lymph node by magnetic selection and highly purified CD169 + CD11b + macrophages by flow cytometry sorting (Fig. 6b) . After preincubating cells for 2 h with particulate lipids, we cultured CD169 + macrophages together with mouse iNKT hybridoma DN32.D3 cells. We found that α-GalCer was efficiently presented by CD169 + cells, as defined by IL-2 production by DN32.D3 cells (Fig. 6c) . To ascertain if iNKT activation is dependent on antigen internalization, we used particles containing Gal(α1→2)α-GalCer, an α-GalCer analog that requires intracellular processing before recognition by iNKT cells 36 . Culture of DN32.D3 cells together with macrophages preincubated with Gal(α1→2)α-GalCer particles induced IL-2 secretion (Fig. 6d) , which indicated that iNKT cell activation is indeed dependent on antigen internalization by macrophages. Moreover, we observed that CD169 + macrophages were able to present antigen to an extent similar to that of CD11c hi DCs purified from mice lymph nodes (Fig. 6e) .
In contrast, lymph node B cells were not able induce IL-2 secretion in cocultured DN32.D3 iNKT cells (Fig. 6e) , in line with their low phagocytic capacity in the absence of specific B cell antigen receptor-mediated uptake 31 . CD169 + macrophages can be distinguished as SCS or medullary macrophages on the basis of F4/80 expression 35 . Therefore, we sought to determine if macrophages from the SCS were able to present lipid antigen by purifying them as CD169 + CD11b + CD11c int F4/80 − cells from mice lymph nodes (Fig. 6f and Supplementary Fig. 7) .
Indeed, we observed that SCS macrophages were able to present lipid antigens to cocultured DN32.D3 iNKT cells, as demonstrated by IL-2 secretion (Fig. 6g) .
Because purified macrophages are able to present lipid antigen to iNKT cells in vitro, we assessed the ability of CD169 + cells to retain and present particulate α-GalCer in vivo. For this, we injected mice with particles coated with α-GalCer or control lipids, purified CD169 + cells from draining lymph nodes 2 h later and incubated them in vitro with DN32.D3 iNKT cells. Only CD169 + macrophages from mice injected with particulate α-GalCer stimulated IL-2 secretion from DN32.D3 cells (Fig. 6h) . In a similar manner, CD169 + cells purified from draining nodes of wild-type mice injected with Gal(α1→2)α-GalCer-coated particles gave rise to IL-2 secretion from cocultured DN32.D3 cells (Fig. 6i) . CD169 + macrophages purified from the draining lymph nodes of mice injected with control particles were unable to induce IL-2 secretion by DN32.D3 cells (Fig. 6h,i) . Furthermore, whereas lymph node DCs were able to present lipid antigen in vitro, neither CD11c hi DCs nor B cells purified from draining lymph nodes 2 h after injection of particulate α-GalCer were able to stimulate IL-2 secretion from cocultured DN32.D3 cells (Fig. 6j) .
Finally, to determine whether CD169 + macrophages can present antigen to primary lymph node iNKT cells, we did presentation assays with CD169 + cells and CFSE-labeled primary iNKT-S1 cells purified from mouse lymph nodes (Fig. 6k,l) . CD169 + macrophages pulsed with particulate α-GalCer were able to induce IFN-γ secretion (Fig. 6k) and the proliferation of primary lymph node iNKT cells, as shown by CFSE dilution (Fig. 6l) . In the absence of macrophages or when iNKT cells were cultured together with CD169 + cells pulsed with control lipids, we detected no proliferation or IFN-γ secretion for primary iNKT cells (Fig. 6k,l) . Thus, CD169 + macrophages internalize antigenic lipids both in vitro and in vivo and can present them in association with CD1d to efficiently activate iNKT cells.
Bacterial glycolipids activate lymph node i NKT cells
To verify our findings with an iNKT cell agonist derived from bacterial glycolipids, we coated silica particles with liposomes containing α-linked galacturonic glycosphingolipid (GSL-1′) expressed by Sphingomonas yanoikuyae, which can activate iNKT cells 5, 37 . We observed that particulate GSL-1′ induced a 1.6-fold increase in the total number of cells in the lymph node compared with that of lymph nodes from mice injected with control particles (Fig. 7a) . This increase was dependent on the presence of iNKT cells, as we did not detect it in J α 18-deficient mice (lacking NKT cells) injected with GSL-1′-coated particles (Fig. 7a) . Although the relative proportion of DCs, B cells and T cells remained the same, lymph node iNKT cells were enriched up to threefold after the injection of particulate GSL-1′ (Fig. 7b) . In addition, we observed that iNKT cells in draining lymph nodes upregulated CD25 and CD69 and produced IFN-γ within a few hours of the administration of particulate GSL-1′ (Fig. 7c-f) . To A r t i c l e s assess whether iNKT cell responses to Sphingomonas glycolipids were also dependent on lymph node-resident macrophages, we specifically depleted mice of lymph node macrophages by CLL treatment. After administration of particulate GSL-1′, iNKT cells were not efficiently activated in the draining lymph nodes of CLL-treated mice, showing CD25 upregulation lower than that of iNKT cells in the lymph nodes from untreated mice (Fig. 7g) . Finally, we adoptively transferred labeled iNKT-S1 cells and CD4 + T cells into wild-type recipients to visualize the dynamics of iNKT cells in response to particulate GSL-1′ (Supplementary Movie 11) . In contrast to CD4 + T cells, iNKT cells showed a significantly lower speed of 7.3 ± 3.6 µm/min at 16 h after the administration of particulate GSL-1′ (Fig. 7h) relative to their average speed in the absence of antigen (11.0 ± 3.1 µm/min; Fig. 1g ). This was accompanied by a greater frequency of long-lasting arrests, reflected by an altered distribution of instantaneous speeds (Fig. 7i) , a higher arrest coefficient (Fig. 7j) and a lower motility coefficient (31.2 ± 9.9 µm 2 /min; Fig. 7k) . Thus, similar to α-GalCer, bacterial glycolipids can mediate the early activation of iNKT cells in draining lymph nodes in a manner dependent on the presence of macrophages.
DISCUSSION
Our study has provided new insight into the early events of iNKT cell activation in the lymph nodes in vivo. We imaged iNKT cells in living lymphoid tissues and have shown that they patrolled the lymph node paracortex in resting conditions. Within minutes of administration, lipid antigens arrived at the SCS of the lymph nodes, where they were retained and presented to iNKT cells. Cognate antigen recognition induced iNKT cell arrest and led to cytokine production and expansion of the iNKT cell population. Finally, we have demonstrated that CD169 + macrophages have a critical role in iNKT cell activation, as they retained, internalized and presented lipids to iNKT cells, acting as true APCs in the lymph nodes. Over the past decade, much effort has been expended in the search for lipid antigens that bind CD1d molecules and activate iNKT cells 2, 14 ; however, very little is known about how and where iNKT cells encounter antigen in vivo. In fact, so far very few studies have achieved the visualization of iNKT cells in situ, probably because of the lack of reliable reagents that allow their identification. In this context, researchers have tried unsuccessfully to visualize iNKT cells by immunohistochemistry using CD1d-tet 29 . In contrast, the use of less stringent markers (such as NK1.1) results in the inclusion of other cell populations, which makes the unequivocal identification of iNKT cells difficult. To circumvent those issues, we used two complementary strategies to purify iNKT cells before labeling the cells, adoptively transferring them and visualizing them by multiphoton microscopy. As we were concerned that the purification of iNKT cells with CD1d-tet could occasionally induce their partial activation 29 , in a first approach we purified iNKT cells from spleen and liver as TCRβ + NK1.1 + cells. However, as lymph node iNKT cells are represented by both NK1.1 + and NK1.1 − cells 28 , we verified our results by purifying iNKT cells from the lymph nodes as TCRβ + CD1d-tet + cells. We detected iNKT cells purified by each strategy in the lymph nodes of recipient mice in similar numbers, and they showed identical location and dynamic activity independently of their tissue of origin or purification method. Despite the fact that iNKT cell number is lower in the lymph nodes than in the spleen or liver, in normal conditions of clonal abundance, the number of iNKT cells in the lymph nodes is between 500 and 5,000 times higher than that of any antigen-specific T cell population 11 . Notably, the number of transferred iNKT cells observed in the lymph nodes was of the same order of magnitude as that of endogenous iNKT cells, which allowed us to analyze iNKT cell dynamics under conditions of typical clonal abundance. Thus, our adoptive-transfer strategy allowed us to avoid the abnormally large number of antigen-specific cells frequently associated with this kind of experiment 38 . Using multiphoton microscopy imaging of living lymph nodes, we observed that iNKT cells in resting conditions were located mainly in the paracortical region, where they moved by random walk with average speed of around 10 µm/min. Accordingly, iNKT cells show dynamics similar to those of classical CD4 + T cells as they scan the lymph node in search of specific antigen 20, 30 .
Although α-GalCer is derived from a marine sponge, it has proven to be a very valuable tool for delineating the pivotal role of iNKT cells in autoimmunity, cancer and host defense 2 . Indeed, the wide availability of this glycolipid allowed us to elucidate the uptake and presentation of lipid antigens in the lymph nodes by CD169 + macrophages that leads to subsequent iNKT cell activation. Our dynamic imaging approach, in concert with our flow cytometry data, demonstrated that iNKT cell activation occurred within a few hours of antigen arrival at the draining lymph node. Furthermore, we confirmed those results, showing that Sphingomonas glycolipids rapidly activated lymph node iNKT cells, inducing IFN-γ secretion and lymph node enlargement and altering the dynamics of iNKT cells in the lymph nodes. In line with the fact that GSL-1′ is a weaker iNKT cell agonist than α-GalCer 5 , its effect on lymph node enlargement and iNKT cell dynamics was less marked than that observed for α-GalCer. However, GSL-1′ was efficient in inducing the activation of lymph node iNKT cells, as measured by upregulation of CD25 and CD69 and secretion of IFN-γ. In agreement with our results, published work has shown how liver iNKT cells are activated in response to the administration of Borrelia burdorgferi, as reflected by an alteration in their dynamics 39 . Therefore, our results point to a pivotal role for iNKT cells in the initiation of immune responses in the lymph nodes to a variety of infectious agents.
Traditionally, iNKT cell activation has been studied through the use of soluble lipids or lipid-pulsed DCs. However, during the course of an infection, antigenic lipids would be more likely to be present in the capsule of different pathogens, such as Sphingomonas, Borrelia or Erlichia [4] [5] [6] . After arriving in the lymph node, particulate antigens are retained in the SCS region, where they can be directly recognized by specific lymphocytes [21] [22] [23] [24] [25] 35 . In agreement with that, we observed that particulate lipids localized in the SCS very rapidly after administration. Subsequently, iNKT cells arrested in the SCS region of the lymph nodes within a few hours of antigen administration. In line with that, naive and memory CD8 + T cells relocate near the SCS region within a few hours of antigen arrival, which allows T cell activation in the lymph node periphery 22, 25 . Although the low number of iNKT cells in the lymph nodes prevents examination of the kinetics of the relocation of iNKT cells to the lymph node periphery, it is conceivable that they would follow a pattern similar to that described for classical αβ T cells. However, lipid antigens could also be presented to iNKT cells in the lymph node cortex by DCs immigrating from peripheral tissues, and in fact skin DCs are able to present antigen to iNKT cells after subcutaneous injection of soluble α-GalCer 13 . However, the migration of DCs to draining lymph nodes takes place several hours after antigen administration and is unlikely to have an important role in initiating very early immune responses 26, 33 . Nevertheless, it is conceivable that both mechanisms of antigen presentation mediated by resident and migratory APCs act together to activate iNKT cells in different lymph node locations at various stages during the immune response. CD169 + macrophages can be classified as SCS or medullary on the basis of F4/80 expression and they show different endocytic and degradative abilities that might influence their function as APCs 35 . Several studies have identified a role for CD169 + macrophages in the SCS in the presentation of native antigen to follicular B cells 23, 24, 35 , and indeed SCS cells seem to have a greater ability to retain antigen on their surface than do medullary macrophages 35 . However, the ability of SCS macrophages to present processed antigen to T cells remains to be established [23] [24] [25] 35 . Our data have provided formal proof that SCS CD169 + macrophages can act as true APCs, internalizing and presenting lipid antigen to iNKT cells, although we did not exclude the possibility that medullary macrophages might also have a role in antigen presentation. Accordingly, depletion of lymph node macrophages by treatment with CLLs severely impaired iNKT cell activation and prevented further proliferation. Although the mechanism that governs the 'decision' of antigen retention or internalization by SCS macrophages has not been characterized, this may depend on the cell surface receptors responsible for antigen binding. Indeed, in DCs, antigen binding through the receptor FcγRIIB leads to the etention and/or recycling of intact antigen to the surface, whereas binding through FcγRI or FcγRIII targets antigen for intracellular degradation 40 . Thus, DCs are able to present antigen to both T cells and B cells 41, 42 . Recognition of microbial lipids by iNKT cells in the context of an infection may require internalization of the pathogen through different sets of surface receptors and the release of the microbial glycolipids in intracellular compartments before loading into CD1d. In line with that, it has been suggested that CD169 (sialoadhesin) could be involved in regulating the function of various immune cells either by favoring cell-cell interactions or by functioning as a phagocytic receptor to clear sialylated pathogens 43 . However, the identification of the molecules expressed on the surface of macrophages that could have a direct role in modulating iNKT cell responses will require further investigation.
The activation of iNKT cells may have important implications for the outcome of immune responses, as these cells have been described as a bridge between adaptive and innate immune responses because of their capacity to make rapid responses that lead to the downstream activation of many other cell types 1, 16, 44 . Indeed, mice lacking iNKT cells have less clearance after infection with several pathogens, such as Sphingomonas or Erlichia 5, 6, 14 . Moreover, iNKT-deficient mice show enhanced mortality in response to infection with influenza virus as a result of lower specific T cell and B cell responses and a population expansion of myeloid-derived suppressor cells 45 . Thus, although we have demonstrated that CD169 + macrophages were able to present antigen to iNKT cells at the start of an immune response, it is conceivable that iNKT cells interact in an antigen-dependent manner with other cell types during the initiation or at later stages of an immune reaction. In this context, it is known that at several hours after injection, antigen-loaded DCs arrive at the lymph nodes, where they are able to interact with antigen-specific T cells 26 . Thus, iNKT cells could interact with lipid-loaded DCs in the lymph nodes, which could lead to an increase in CD4 + and CD8 + T cell responses 16, 44 . In addition, the role of iNKT cells in helping antigen-specific B cell proliferation and antibody production is well established 31, 46, 47 . Specific B cells take up antigen after its arrival at the lymph nodes and subsequently migrate toward the border between the B cell and T cell areas, where they form stable conjugates with antigen-specific T cells 48 . Our preliminary data have suggested that B cell-iNKT cell interactions can take place in the lymph nodes within 1-2 d of antigen administration and result in B cell activation and proliferation (P.B. and F.D.B, unpublished data). Consequently, it is conceivable that SCS macrophages act as a platform to allow antigen presentation to iNKT cells at the beginning of an immune response, whereas later B cell-iNKT cell interactions would favor the development of adaptive immune responses. Accordingly, this adjuvant-like feature of iNKT cells makes them a good candidate for the design of new vaccination strategies 1 . Further studies to target antigen to SCS macrophages that facilitate fast iNKT cell activation might allow improved vaccination approaches.
METHODS
Methods and any associated references are available in the online version of the paper at http://www.nature.com/natureimmunology/.
Note: Supplementary information is available on the Nature Immunology website.
